http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2025, Vol. 34 ›› Issue (9): 882-890.DOI: 10.5246/jcps.2025.09.065

• 【研究论文】 • 上一篇    下一篇

高等药学院校博士后学术成长因素实证分析——以北京大学药学院为例

王珣1,*(), 杨林洁2   

  1. 1. 北京大学医学部 药学院, 北京 100191
    2. 中国医学科学院药物研究所, 北京 100050
  • 收稿日期:2025-03-12 修回日期:2025-04-13 接受日期:2025-05-08 出版日期:2025-10-02 发布日期:2025-10-02
  • 通讯作者: 王珣

Empirical analysis of factors influencing postdoctoral academic growth in pharmaceutical schools and universities: A case study of Peking University School of Pharmaceutical Sciences

Xun Wang1,*(), Linjie Yang2   

  1. 1 School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
    2 Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
  • Received:2025-03-12 Revised:2025-04-13 Accepted:2025-05-08 Online:2025-10-02 Published:2025-10-02
  • Contact: Xun Wang

摘要:

高等药学院校是药学博士后培养的重要基地, 本研究旨在对高等药学院校博士后科研产出的关键因素进行实证分析。研究纳入北京大学药学院2016年10月后入站、2024年12月底前出站的博士后, 收集基本信息及其在站期间的科研产出。以博士后期间主持省部级及以上科研基金、发表论文、申请专利作为博士后成长良好的指标, 并通过Logistic回归分析关键影响因素。研究发现, 入选博士后激励计划的博士后获得基金、高水平基金, 以及发表论文、高水平论文的比例明显更高。跨学科博士后获得基金、高水平基金的比例明显更低。在站时间越长发表高水平论文, 申请专利的概率明显越高。药物分析学博士后获得高水平基金的比例明显更高, 药剂学博士后发表论文的比例明显更高。合作导师具有海外经历的, 博士后获得专利的比例更高; 合作导师属于预聘-长聘制系列的, 博士后获得专利的比例更低。研究建议高等药学院校博士后管理部门应加强博士后进站遴选、加大博士后激励计划宣传力度, 加深跨学科博士后对药学专业的理解, 加强药学博士后在站管理, 促进药学博士后的成长。

关键词: 高等药学院校, 博士后, 学术成长因素

Abstract:

Universities serve as pivotal platforms for cultivating postdoctoral talent, particularly in pharmaceutical sciences. This study provided an empirical assessment of the key determinants influencing research productivity among postdoctoral fellows in this field. We analyzed a cohort of postdoctoral researchers who entered the School of Pharmaceutical Sciences at Peking University between October 2016 and December 2024, gathering comprehensive data on their demographic characteristics and scholarly accomplishments throughout their fellowship. Indicators of postdoctoral success encompassed securing research funding, publishing scholarly articles, and filing patent applications. To identify the principal factors shaping these outcomes, we employed logistic regression analysis. The findings demonstrated that postdoctoral fellows enrolled in incentive programs exhibited markedly higher success rates in acquiring research grants, especially high-tier funding, as well as in publishing both general and high-impact research articles. Conversely, fellows engaged in interdisciplinary research showed significantly reduced success rates in obtaining both general and high-level grants. Additionally, extended fellowship durations were positively correlated with greater likelihoods of publishing high-impact papers and achieving patents. Notably, postdoctoral fellows specializing in Pharmaceutical Analysis had a significantly higher probability of securing prestigious research grants, while those focusing on Pharmaceutics demonstrated a superior capacity for research publication. Regarding intellectual property, fellows mentored by supervisors with overseas experience were substantially more likely to obtain patents, whereas those guided by tenure-track supervisors exhibited lower patent acquisition rates. In light of these insights, we proposed several recommendations for postdoctoral management bodies within pharmaceutical academic institutions. These included refining selection criteria for postdoctoral candidates, amplifying support through incentive mechanisms, enhancing interdisciplinary fellows’ integration into pharmaceutical research paradigms, and optimizing postdoctoral training frameworks to nurture academic excellence and research innovation.

Key words: Pharmaceutical Sciences schools and universities, Postdoctoral fellows, Academic growth factors

Supporting: